DVN vs STRO · P/E 7.4, rev $17.19B vs rev $62.0M
Devon Energy Corporation (DVN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DVN revenue for 2025-12-31 was $17.19B. Net income was $2.64B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DVN currently screens at market cap $22.42B and trailing P/E 7.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DVN and STRO stock pages for the full models.
Not investment advice.